Suppr超能文献

肌痛性脑脊髓炎/慢性疲劳综合征和新冠后疾病患者的发病表现和生活质量:一项澳大利亚初步横断面研究。

Illness presentation and quality of life in myalgic encephalomyelitis/chronic fatigue syndrome and post COVID-19 condition: a pilot Australian cross-sectional study.

机构信息

National Centre for Neuroimmunology and Emerging Diseases, Griffith University, Gold Coast, QLD, 4222, Australia.

Consortium Health International for Myalgic Encephalomyelitis, Griffith University, Gold Coast, QLD, 4222, Australia.

出版信息

Qual Life Res. 2024 Sep;33(9):2489-2507. doi: 10.1007/s11136-024-03710-3. Epub 2024 Jul 3.

Abstract

PURPOSE

Post COVID-19 Condition (PCC), being persistent COVID-19 symptoms, is reminiscent of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-a chronic multi-systemic illness characterised by neurocognitive, autonomic, endocrinological and immunological disturbances. This novel cross-sectional investigation aims to: (1) compare symptoms among people with ME/CFS (pwME/CFS) and people with PCC (pwPCC) to inform developing PCC diagnostic criteria; and (2) compare health outcomes between patients and people without acute or chronic illness (controls) to highlight the illness burdens of ME/CFS and PCC.

METHODS

Sociodemographic and health outcome data were collected from n = 61 pwME/CFS, n = 31 pwPCC and n = 54 controls via validated, self-administered questionnaires, including the 36-Item Short-Form Health Survey version 2 (SF-36v2) and World Health Organization Disability Assessment Schedule version 2.0 (WHODAS 2.0). PwME/CFS and pwPCC also provided self-reported severity and frequency of symptoms derived from the Canadian and International Consensus Criteria for ME/CFS and the World Health Organization case definition for PCC.

RESULTS

Both illness cohorts similarly experienced key ME/CFS symptoms. Few differences in symptoms were observed, with memory disturbances, muscle weakness, lymphadenopathy and nausea more prevalent, light-headedness more severe, unrefreshed sleep more frequent, and heart palpitations less frequent among pwME/CFS (all p < 0.05). The ME/CFS and PCC participants' SF-36v2 or WHODAS 2.0 scores were comparable (all p > 0.05); however, both cohorts returned significantly lower scores in all SF-36v2 and WHODAS 2.0 domains when compared with controls (all p < 0.001).

CONCLUSION

This Australian-first investigation demonstrates the congruent and debilitating nature of ME/CFS and PCC, thereby emphasising the need for multidisciplinary care to maximise patient health outcomes.

摘要

目的

新冠后状况(PCC)是指持续的新冠症状,使人联想到慢性疲劳综合征/肌痛性脑脊髓炎(ME/CFS)——一种以神经认知、自主神经、内分泌和免疫紊乱为特征的慢性多系统疾病。本项新的横断面研究旨在:(1)比较 ME/CFS(pwME/CFS)和 PCC(pwPCC)患者的症状,以制定 PCC 诊断标准;(2)比较患者与无急性或慢性疾病的人群(对照组)的健康结果,以突出 ME/CFS 和 PCC 的疾病负担。

方法

通过经过验证的自我管理问卷,收集了 61 名 pwME/CFS、31 名 pwPCC 和 54 名对照组患者的社会人口学和健康结果数据,包括 36 项简短健康调查第 2 版(SF-36v2)和世界卫生组织残疾评估表第 2.0 版(WHODAS 2.0)。pwME/CFS 和 pwPCC 还提供了源自加拿大和国际 ME/CFS 共识标准以及世界卫生组织 PCC 病例定义的自我报告的症状严重程度和频率。

结果

两个疾病队列均经历了关键的 ME/CFS 症状。观察到症状存在一些差异,pwME/CFS 患者记忆障碍、肌肉无力、淋巴结病和恶心更为常见,头晕更严重,睡眠无法恢复更频繁,心悸更不频繁(均 p<0.05)。ME/CFS 和 PCC 参与者的 SF-36v2 或 WHODAS 2.0 评分相似(均 p>0.05);然而,与对照组相比,两个队列在所有 SF-36v2 和 WHODAS 2.0 领域的评分均显著降低(均 p<0.001)。

结论

这项澳大利亚首次调查表明 ME/CFS 和 PCC 的症状一致且具有致残性,从而强调需要多学科护理来最大程度地提高患者的健康结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ffa/11390810/5996d6b661ab/11136_2024_3710_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验